Stay updated on Nivolumab in CNS and Testicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study record no longer lists the NIH grant/contract identifier “2016,” and the site revision advances from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-22T12:23:28.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The study record and its displayed details appear unchanged.
    Difference
    0.0%
    Check dated 2026-11-15T12:13:18.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the nivolumab study in relapsed or refractory PCNSL and PTL is available, with study details, results measures, eligibility requirements, and participating locations.
    Difference
    70%
    Check dated 2026-11-08T11:48:01.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-11-01T12:25:08.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T12:24:23.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T13:22:26.000Z thumbnail image

Stay in the know with updates to Nivolumab in CNS and Testicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in CNS and Testicular Lymphoma Clinical Trial page.